Search Results | Pediatrics | American Academy of Pediatrics

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Improvement in Disease Severity and Pruritus Outcomes With Crisaborole Ointment, 2%, by Baseline Atopic Dermatitis Severity in Children and Adolescents With Mild-to-Moderate Atopic Dermatitis

Grace T. Padron, MD

Pediatrics (2021) 148 (Supplement 3): S18–S19.

Published: December 2021

View article

Journal Articles

Long-term Safety of Crisaborole Ointment 2% in Children and Adults With Mild-to-Moderate Atopic Dermatitis

Annely M. Richardson, MD, Thanai Pongdee, MD

Pediatrics (2018) 142 (Supplement_4): S230.

Published: December 2018

View article

Journal Articles

Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials

Amy S. Paller, MS, MD, Gil Yosipovitch, MD, Wynnis L. Tom, MD, Mark Lebwohl, MD, Mark Boguniewicz, MD ...

Pediatrics (2018) 142 (1_MeetingAbstract): 814.

Published: May 2018

View article

Journal Articles

Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials

Amy S. Paller, MS, MD, Gil Yosipovitch, MD, Wynnis L. Tom, MD, Mark Lebwohl, MD, Mark Boguniewicz, MD ...

Pediatrics (2018) 142 (1_MeetingAbstract): 815.

Published: May 2018

View article

Journal Articles

Phase 3 Studies Treating Children and Adult Patients with Mild to Moderate Atopic Dermatitis with Crisaborole Ointment, a Novel, Nonsteroidal, Topical Anti-inflammatory, Phosphodiesterase 4 Inhibitor

Amy S. Paller, MS, MD, Wynnis L. Tom, MD, Mark G. Lebwohl, MD, Mark Boguniewicz, MD, Lawrence F. Eichenfield, MD ...

Pediatrics (2018) 141 (1_MeetingAbstract): 275.

Published: January 2018

View article

Journal Articles

A Novel Nonsteroidal, Topical Anti-inflammatory, Phosphodiesterase 4 Inhibitor, Crisaborole Ointment, Reduced Pruritus and Signs of Atopic Dermatitis in 2 Phase 3 Studies in Children and Adults

Adelaide A. Hebert, MD, Lawrence F. Eichenfield, MD, Mark G. Lebwohl, MD, Amy S. Paller, MS, MD, Eric L. Simpson, MD ...

Pediatrics (2018) 141 (1_MeetingAbstract): 251.

Published: January 2018

View article

Journal Articles

Efficacy and Safety of Crisaborole Ointment, a Novel, Nonsteroidal Phosphodiesterase 4 (PDE4) Inhibitor for the Topical Treatment of Atopic Dermatitis (AD) in Children and Adults

Thanai Pongdee, MD

Pediatrics (2017) 140 (Supplement_3): S207.

Published: December 2017

View article

Journal Articles

Intermittent Therapy for Flare Prevention and Long-term Disease Control in Stabilized Atopic Dermatitis: A Randomized Comparison of 3-Times-Weekly Applications of Tacrolimus Ointment Versus Vehicle

Laura Gober, MD, Jonathan M. Spergel, MD, PhD

Pediatrics (2009) 124 (Supplement_2): S131–S132.

Published: November 2009

View article

Journal Articles

Three Times Weekly Tacrolimus Ointment Reduces Relapse in Stabilized Atopic Dermatitis: A New Paradigm for Use

Satyen Gada, MD, Susan Laubach, MD

Pediatrics (2009) 124 (Supplement_2): S132.

Published: November 2009

View article

Journal Articles

Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease Severity

Jennifer T. Huang, MD, Melissa Abrams, MD, Brook Tlougan, MD, Alfred Rademaker, PhD, Amy S. Paller, MD

Pediatrics (2009) 123 (5): e808–e814.

Published: May 2009

View article

Journal Articles

Three Times Weekly Tacrolimus Ointment Reduces Relapse in Stabilized Atopic Dermatitis: A New Paradigm for Use

Amy S. Paller, MD, Lawrence F. Eichenfield, MD, Robert S. Kirsner, MD, PhD, Toni Shull, RN, Eileen Jaracz, PharmD ...

Pediatrics (2008) 122 (6): e1210–e1218.

Published: December 2008

View article

Journal Articles

Intermittent Therapy for Flare Prevention and Long-term Disease Control in Stabilized Atopic Dermatitis: A Randomized Comparison of 3-Times-Weekly Applications of Tacrolimus Ointment Versus Vehicle

Jonathan M. Spergel, MD, PhD

Pediatrics (2008) 122 (Supplement_4): S199.

Published: November 2008

View article

Journal Articles

Efficacy and Safety of Tacrolimus Ointment Treatment for up to 4 Years in Patients With Atopic Dermatitis

Jonathan M. Spergel, MD, PhD

Pediatrics (2006) 118 (Supplement_1): S16.

Published: August 2006

View article

Journal Articles

Can Tacrolimus Ointment (Protopic) Exacerbate an Intercurrent Fungal Infection?: In Reply

Lawrence A. Schachner, MD

Pediatrics (2006) 117 (6): 2326.

Published: June 2006

View article

Journal Articles

Can Tacrolimus Ointment (Protopic) Exacerbate an Intercurrent Fungal Infection?

David E. Bronstein, MD, James D. Cherry, MD

Pediatrics (2006) 117 (6): 2325–2326.

Published: June 2006

View article

Journal Articles

Tacrolimus Ointment 0.03% Is Safe and Effective for the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Patients: Results From a Randomized, Double-Blind, Vehicle-Controlled Study

Lawrence A. Schachner, MD, Cindy Lamerson, MD, Mary P. Sheehan, MD, Mark Boguniewicz, MD, Joy Mosser, MD ...

Pediatrics (2005) 116 (3): e334–e342.

Published: September 2005

View article

Journal Articles

The Effect of Prophylactic Ointment Therapy on Nosocomial Sepsis Rates and Skin Integrity in Infants With Birth Weights of 501 to 1000 g

William H. Edwards, MD, Jeanette M. Conner, MS, PhD, Roger F. Soll, MD, for the Vermont Oxford Network Neonatal Skin Care Study Group

Pediatrics (2004) 113 (5): 1195–1203.

Published: May 2004

View article

Journal Articles

EFFICACY AND SAFETY OF TACROLIMUS OINTMENT COMPARED WITH THAT OF HYDROCORTISONE ACETATE OINTMENT IN CHILDREN WITH ATOPIC DERMATITIS

Stacie M. Jones, MD

Pediatrics (2003) 112 (Supplement_2): 461–462.

Published: August 2003

View article

Journal Articles

Systemic Candidiasis in Extremely Low Birth Weight Infants Receiving Topical Petrolatum Ointment for Skin Care: A Case–Control Study

Judith R. Campbell, MD, Elena Zaccaria, MASCP, Carol J. Baker, MD

Pediatrics (2000) 105 (5): 1041–1045.

Published: May 2000

View article

Journal Articles

Ichthyosis is Not Transmitted Through Skin Ointment

Yelva Lynfield

Pediatrics (1995) 95 (3): 456.

Published: March 1995

View article

NARROW

Improvement in Disease Severity and Pruritus Outcomes With Crisaborole Ointment, 2%, by Baseline Atopic Dermatitis Severity in Children and Adolescents With Mild-to-Moderate Atopic Dermatitis

Long-term Safety of Crisaborole Ointment 2% in Children and Adults With Mild-to-Moderate Atopic Dermatitis

Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials

Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials

Phase 3 Studies Treating Children and Adult Patients with Mild to Moderate Atopic Dermatitis with Crisaborole Ointment, a Novel, Nonsteroidal, Topical Anti-inflammatory, Phosphodiesterase 4 Inhibitor

A Novel Nonsteroidal, Topical Anti-inflammatory, Phosphodiesterase 4 Inhibitor, Crisaborole Ointment, Reduced Pruritus and Signs of Atopic Dermatitis in 2 Phase 3 Studies in Children and Adults

Efficacy and Safety of Crisaborole Ointment, a Novel, Nonsteroidal Phosphodiesterase 4 (PDE4) Inhibitor for the Topical Treatment of Atopic Dermatitis (AD) in Children and Adults

Intermittent Therapy for Flare Prevention and Long-term Disease Control in Stabilized Atopic Dermatitis: A Randomized Comparison of 3-Times-Weekly Applications of Tacrolimus Ointment Versus Vehicle

Three Times Weekly Tacrolimus Ointment Reduces Relapse in Stabilized Atopic Dermatitis: A New Paradigm for Use

Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease Severity

Three Times Weekly Tacrolimus Ointment Reduces Relapse in Stabilized Atopic Dermatitis: A New Paradigm for Use

Intermittent Therapy for Flare Prevention and Long-term Disease Control in Stabilized Atopic Dermatitis: A Randomized Comparison of 3-Times-Weekly Applications of Tacrolimus Ointment Versus Vehicle

Efficacy and Safety of Tacrolimus Ointment Treatment for up to 4 Years in Patients With Atopic Dermatitis

Can Tacrolimus Ointment (Protopic) Exacerbate an Intercurrent Fungal Infection?: In Reply

Can Tacrolimus Ointment (Protopic) Exacerbate an Intercurrent Fungal Infection?

Tacrolimus Ointment 0.03% Is Safe and Effective for the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Patients: Results From a Randomized, Double-Blind, Vehicle-Controlled Study

The Effect of Prophylactic Ointment Therapy on Nosocomial Sepsis Rates and Skin Integrity in Infants With Birth Weights of 501 to 1000 g

EFFICACY AND SAFETY OF TACROLIMUS OINTMENT COMPARED WITH THAT OF HYDROCORTISONE ACETATE OINTMENT IN CHILDREN WITH ATOPIC DERMATITIS

Systemic Candidiasis in Extremely Low Birth Weight Infants Receiving Topical Petrolatum Ointment for Skin Care: A Case–Control Study

Ichthyosis is Not Transmitted Through Skin Ointment

Email alerts

Journals

Books

News

Solutions

Policy

Licensing & Permissions

Advertising

Email alerts

Journals

News

Solutions

This Feature Is Available To Subscribers Only